본문 바로가기

Data Plus(+)

All 807,818 Page 19,914/80,782

검색

Contents

No Journal_name Subject Date DOI Author
608688 ONCOTARGETS AND THERAPY

LOC441178 Overexpression Inhibits the Proliferation and Migration of Esophageal Carcinoma Cells via Methylation of miR-182

2020-11-01 10.2147/ott.s271711 Hu Weitao, Chen Zongchi, Chen Jiangmu, Cai Daxing, Chen Congjie, Fang Taiyong
608687 FUSION ENGINEERING AND DESIGN Organizing Wendelstein 7-X device operation | Organizing Wendelstein 7-X device operation 2020-11-01 10.1016/j.fusengdes.2020.111843 van Eeten P., Bosch H.S., Brakel R., Degenkolbe S.
608686 AMERICAN JOURNAL OF KIDNEY DISEASES : THE OFFICIAL JOURNAL OF THE NATIONAL KIDNEY FOUNDATION No Obvious Impact of NSAIDs on Risk of Kidney Failure: Causal or Another Selection Bias? 2020-11-01 10.1053/j.ajkd.2020.05.023 Lin Ming-Yen, Hwang Shang-Jyh, Chiu Yi-Wen
608685 NEURO-ONCOLOGY IMMU-33. MULTI-ANTIGEN RECOGNITION CIRCUITS OVERCOME CHALLENGES OF SPECIFICITY, HETEROGENEITY, AND DURABILITY IN T-CELL THERAPY FOR GLIOBLASTOMA | IMMU-33. MULTI-ANTIGEN RECOGNITION CIRCUITS OVERCOME CHALLENGES OF SPECIFICITY, HETEROGENEITY, AND DURABILIT 2020-11-01 10.1093/neuonc/noaa215.463 Watchmaker Payal, Choe Joseph, Simic Milos, Gilbert Ryan, li Aileen, Krasnow Nira, Carrera Diego, Yu Wei, Downey Kira, Celli Anna, Cho Juhyun, Briones Jessica, Dannenfelser Ruth, Cardarelli Lia, Sidhu Sachdev, Roybal Kole, Lim Wendell, Okada Hideho
608684 NEURO-ONCOLOGY EXTH-32. TARGETED STAT3 INHIBITION IMPAIRS MDSC MOBILIZATION AND RECRUITMENT IN GLIOBLASTOMA | EXTH-32. TARGETED STAT3 INHIBITION IMPAIRS MDSC MOBILIZATION AND RECRUITMENT IN GLIOBLASTOMA 2020-11-01 10.1093/neuonc/noaa215.386 von Roemeling Christina, Li Chenglong, Mitchell Duane
608683 NEURO-ONCOLOGY CTNI-31. INTERIM RESULTS OF A PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BBB OPENING WITH THE SONOCLOUD-9 IMPLANTABLE ULTRASOUND DEVICE IN RECURRENT GLIOBLASTOMA PATIENTS PRIOR TO IV CARBOPLATIN | CTNI-31. INTERIM RESULTS OF A PHASE I/IIA ST 2020-11-01 10.1093/neuonc/noaa215.198 Idbaih Ahmed, Ducray François, Stupp Roger, Baize Nathalie, Chinot Olivier, de Groot John, Guyotat Jacques, Sonabend Adam, Menei Philippe, Dufour Henry, Weinberg Jeffrey, Desseaux Carole, Canney Michael, Schmitt Charlotte, Carpentier Alexandre
608682 NEURO-ONCOLOGY BIOM-41. GENETIC MARKERS CORRELATED WITH PROGRESSION-FREE SURVIVAL TIMES IN GLIOBLASTOMA PATIENTS UNDERGOING TREATMENT WITH TUMOR TREATING FIELDS | BIOM-41. GENETIC MARKERS CORRELATED WITH PROGRESSION-FREE SURVIVAL TIMES IN GLIOBLASTOMA PATIENTS UNDERGOIN 2020-11-01 10.1093/neuonc/noaa215.040 Monson Caitlin, Tipps Megan, Jackson Kelsey, Tierney Meghan, Banerji Nilanjana, Trusheim John
608681 REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY: JOURNAL OF GREATPOLAND CANCER CENTER IN POZNÁN AND POLISH SOCIETY OF RADIATION ONCOLOGY Survival and consolidative radiotherapy in patients living with HIV and treated for diffuse large B-cell lymphoma 2020-11-01 10.1016/j.rpor.2020.09.004 Casimiro Lucas Coelho, Mauro Geovanne Pedro, Medici Carolina Trindade Mello, Weltman Eduardo
608680 NANOMATERIALS Role of Substrate in Au Nanoparticle Decoration by Electroless Deposition 2020-11-01 10.3390/nano10112180 Bruno Luca, Urso Mario, Shacham-Diamand Yosi, Priolo Francesco, Mirabella Salvo
608679 JOURNAL FOR IMMUNOTHERAPY OF CANCER Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy 2020-11-01 10.1136/jitc-2020-001156 Gao Hannan, Wu Yue, Shi Jiyun, Zhang Xin, Liu Tianyu, Hu Biao, Jia Bing, Wan Yakun, Liu Zhaofei, Wang Fan